Im SA - Search Results

1

New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).

Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Kim JH, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, Kwon J, Kang KM, Chung WK, Kim KS, Yoon WS, Kim JH, Cha J, Oh YK, Kim IA. Kim JS, et al. Among authors: im sa. Breast Cancer Res Treat. 2021 Apr;186(2):453-462. doi: 10.1007/s10549-020-06043-0. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33392845

2

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, Chang KH, Kim NK. Kim TM, et al. Among authors: im sa. Blood. 2005 Dec 1;106(12):3785-90. doi: 10.1182/blood-2005-05-2056. Epub 2005 Aug 18. Blood. 2005. PMID: 16109779 Free article.

3

Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer.

Kim JH, Oh DY, Kim YJ, Han SW, Choi IS, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Kim JH, et al. Among authors: im sa. J Korean Med Sci. 2005 Oct;20(5):806-10. doi: 10.3346/jkms.2005.20.5.806. J Korean Med Sci. 2005. PMID: 16224154 Free PMC article.

4

Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.

Han SW, Kim TY, Jeon YK, Hwang PG, Im SA, Lee KH, Kim JH, Kim DW, Heo DS, Kim NK, Chung DH, Bang YJ. Han SW, et al. Among authors: im sa. Clin Cancer Res. 2006 Apr 15;12(8):2538-44. doi: 10.1158/1078-0432.CCR-05-2845. Clin Cancer Res. 2006. PMID: 16638863

5

Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.

Lee KW, Kim JH, Park JH, Kim HP, Song SH, Kim SG, Kim TY, Jong HS, Jung KH, Im SA, Kim TY, Kim NK, Bang YJ. Lee KW, et al. Among authors: im sa. Anticancer Res. 2006 Sep-Oct;26(5A):3429-38. Anticancer Res. 2006. PMID: 17094463 Free article.

6

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Lee KH, et al. Among authors: im sa. BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63. BMC Cancer. 2007. PMID: 17430582 Free PMC article.

7

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.

Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Keam B, et al. Among authors: im sa. BMC Cancer. 2007 Nov 1;7:203. doi: 10.1186/1471-2407-7-203. BMC Cancer. 2007. PMID: 17976237 Free PMC article.

8

Weight changes after adjuvant treatment in Korean women with early breast cancer.

Han HS, Lee KW, Kim JH, Kim SW, Kim IA, Oh DY, Im SA, Bang SM, Lee JS. Han HS, et al. Among authors: im sa. Breast Cancer Res Treat. 2009 Mar;114(1):147-53. doi: 10.1007/s10549-008-9984-6. Epub 2008 Mar 26. Breast Cancer Res Treat. 2009. PMID: 18365310

9

Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).

Lee SG, Jee YG, Chung HC, Kim SB, Ro J, Im YH, Im SA, Seo JH. Lee SG, et al. Among authors: im yh, im sa. Breast Cancer Res Treat. 2009 Apr;114(3):589-95. doi: 10.1007/s10549-008-0035-0. Epub 2008 Apr 25. Breast Cancer Res Treat. 2009. PMID: 18437555

10

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.

Keam B, Im SA, Han SW, Ham HS, Kim MA, Oh DY, Lee SH, Kim JH, Kim DW, Kim TY, Heo DS, Kim WH, Bang YJ. Keam B, et al. Among authors: im sa. BMC Cancer. 2008 May 27;8:148. doi: 10.1186/1471-2407-8-148. BMC Cancer. 2008. PMID: 18505590 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

665 results

Search Page